Integrated Mendelian randomization and single-cell RNA-sequencing analyses identified OAS1 as a novel therapeutic target for erectile dysfunction via targeting fibroblasts

Abstract Clinically, phosphodiesterase type 5 inhibitors (PDE5-Is) remain the first-line therapy for erectile dysfunction (ED) patients; however, approximately 35% of these patients are still failing to respond to the therapeutic effects. So, urgent needs are required to identify novel therapeutic t...

Descripció completa

Dades bibliogràfiques

Autors principals:	Yi Wang, Guihua Chen, Deng Li
Format:	Artigo
Idioma:	Inglês
Publicat:	BMC 2024-12-01
Col·lecció:	Biology Direct
Matèries:	Mendelian randomization OAS1 Single-cell RNA-sequencing Erectile dysfunction Fibroblasts
Accés en línia:	https://doi.org/10.1186/s13062-024-00587-7
Etiquetes:	Afegir etiqueta Sense etiquetes, Sigues el primer a etiquetar aquest registre!